Kazakhstan vs Libya: Cause of death, by non-communicable diseases, ages 15-59, male
Kazakhstan
46.9%
in 2021
Libya
47.6%
in 2021
Kazakhstan rank
107th
Libya rank
104th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Kazakhstan
- Libya
How they compare
Libya currently reports 47.6% against 46.9% in Kazakhstan, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Kazakhstan ahead.
Kazakhstan ranks 107th and Libya ranks 104th of 185 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.0% | 50.7% | 8.3% | Kazakhstan |
| 2010s | 67.1% | 47.7% | 19.4% | Kazakhstan |
| 2020s | 52.8% | 47.8% | 5.0% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Kazakhstan or Libya?
- Libya, at 47.6% against 46.9% in Kazakhstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Kazakhstan and Libya?
- 0.7%, with Libya ahead.
- How many years of comparable data are there for Kazakhstan and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Libya rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Kazakhstan ranks 107th and Libya ranks 104th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.